Filing Flows › Inspire Medical Systems (INSP) › Q2 2026 › vs Q2 2025
Inspire Medical Systems (INSP) Q2 2026 vs Q2 2025 (year over year)
Inspire Medical Systems's revenue fell $16.5M (-8%) from $217M in Q2 2025 to $201M in Q2 2026.
Inspire Medical Systems, Q2 2026: revenue $201M (-8% year over year), operating margin -0.3%, net earnings $314K, operating cash flow $23.2M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 7.0% | -2.9% | +9.9 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $201M | $217M | −$16.5M | -8% |
| Other income, net | $3.6M | $984K | $2.6M | +269% |
| Costs & expenses | $204M | $222M | −$17.5M | -8% |
| Operating costs | $201M | $220M | −$19.3M | -9% |
| Income tax | $2.8M | $1.3M | $1.5M | +122% |
| Net earnings | $314K | −$3.6M | $3.9M | — |
| Cost of revenue | $29.1M | $34.7M | −$5.5M | -16% |
| Research & development | $24.7M | $26.2M | −$1.5M | -6% |
| SG&A | $147M | $160M | −$12.2M | -8% |
| Operating cash sources | $36.1M | $41.5M | −$5.4M | -13% |
| Depreciation & amortization | $4.6M | $3.4M | $1.2M | +35% |
| Share-based compensation | $31.2M | $41.7M | −$10.5M | -25% |
| Working capital & other | $12.9M | $38.8M | −$26.0M | -67% |
| Operating cash flow | $23.2M | $2.7M | $20.5M | +765% |
| Free cash flow (OCF − capex) | $14.1M | −$6.3M | $20.4M | — |
| Capital expenditures | $9.2M | $9.0M | $163K | +2% |
Questions
How much did Inspire Medical Systems's revenue grow year over year in Q2 2026?
Inspire Medical Systems's revenue fell $16.5M (-8%) from $217M in Q2 2025 to $201M in Q2 2026.